Ram Nagaraj
Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lens, Crystalline | 45 | 2023 | 90 | 13.470 |
Why?
| Crystallins | 26 | 2023 | 39 | 6.710 |
Why?
| Glycation End Products, Advanced | 22 | 2021 | 57 | 5.510 |
Why?
| Molecular Chaperones | 17 | 2022 | 157 | 4.380 |
Why?
| Cataract | 23 | 2021 | 185 | 4.180 |
Why?
| Epithelial Cells | 15 | 2021 | 951 | 4.040 |
Why?
| alpha-Crystallin B Chain | 11 | 2020 | 18 | 3.820 |
Why?
| Epithelial-Mesenchymal Transition | 7 | 2021 | 167 | 3.770 |
Why?
| Transforming Growth Factor beta2 | 6 | 2021 | 31 | 3.460 |
Why?
| Kynurenine | 10 | 2016 | 81 | 3.120 |
Why?
| Lysine | 17 | 2023 | 242 | 3.030 |
Why?
| Pyruvaldehyde | 16 | 2020 | 27 | 2.810 |
Why?
| alpha-Crystallin A Chain | 7 | 2020 | 8 | 2.790 |
Why?
| Presbyopia | 4 | 2023 | 11 | 2.520 |
Why?
| Apoptosis | 13 | 2019 | 2363 | 2.420 |
Why?
| Capsule Opacification | 4 | 2020 | 20 | 2.000 |
Why?
| Maillard Reaction | 16 | 2015 | 17 | 1.920 |
Why?
| Eye Proteins | 6 | 2018 | 70 | 1.910 |
Why?
| Glaucoma | 3 | 2022 | 202 | 1.890 |
Why?
| alpha-Crystallins | 7 | 2019 | 8 | 1.860 |
Why?
| Arginine | 13 | 2020 | 238 | 1.790 |
Why?
| Aging | 15 | 2020 | 1618 | 1.620 |
Why?
| Ocular Hypertension | 2 | 2022 | 61 | 1.560 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 8 | 2018 | 44 | 1.520 |
Why?
| Ascorbic Acid | 7 | 2017 | 110 | 1.330 |
Why?
| Receptor for Advanced Glycation End Products | 3 | 2021 | 29 | 1.310 |
Why?
| Sirtuins | 2 | 2019 | 32 | 1.290 |
Why?
| HSP27 Heat-Shock Proteins | 3 | 2015 | 11 | 1.280 |
Why?
| Lens Capsule, Crystalline | 2 | 2021 | 9 | 1.270 |
Why?
| Sirtuin 3 | 2 | 2019 | 52 | 1.250 |
Why?
| Diabetes Mellitus, Experimental | 7 | 2020 | 160 | 1.120 |
Why?
| Retinal Ganglion Cells | 3 | 2022 | 92 | 1.040 |
Why?
| Glutathione | 7 | 2020 | 293 | 1.030 |
Why?
| Peptides | 4 | 2015 | 848 | 0.950 |
Why?
| Animals | 44 | 2023 | 31706 | 0.940 |
Why?
| Cattle | 18 | 2020 | 920 | 0.910 |
Why?
| Tetroses | 3 | 2020 | 4 | 0.840 |
Why?
| Acetylation | 7 | 2023 | 211 | 0.840 |
Why?
| Ultraviolet Rays | 2 | 2017 | 363 | 0.830 |
Why?
| Chromatography, Liquid | 5 | 2023 | 347 | 0.830 |
Why?
| Antibodies, Monoclonal | 5 | 2019 | 1262 | 0.830 |
Why?
| Blotting, Western | 12 | 2019 | 1147 | 0.820 |
Why?
| Mice | 17 | 2023 | 14869 | 0.810 |
Why?
| Diabetic Retinopathy | 2 | 2021 | 149 | 0.790 |
Why?
| Tandem Mass Spectrometry | 5 | 2023 | 412 | 0.790 |
Why?
| Disease Models, Animal | 6 | 2022 | 3535 | 0.740 |
Why?
| Kynurenine 3-Monooxygenase | 1 | 2020 | 3 | 0.700 |
Why?
| Ornithine | 5 | 2008 | 18 | 0.700 |
Why?
| Kynurenic Acid | 1 | 2020 | 11 | 0.690 |
Why?
| Glycosylation | 8 | 2020 | 130 | 0.690 |
Why?
| Posterior Capsule of the Lens | 1 | 2020 | 10 | 0.680 |
Why?
| Malonates | 1 | 2019 | 7 | 0.680 |
Why?
| Heat-Shock Proteins | 4 | 2022 | 113 | 0.680 |
Why?
| Propionates | 1 | 2019 | 34 | 0.670 |
Why?
| Chromatography, High Pressure Liquid | 15 | 2010 | 470 | 0.660 |
Why?
| Humans | 61 | 2023 | 114689 | 0.610 |
Why?
| Cysteine | 2 | 2010 | 171 | 0.610 |
Why?
| Reperfusion Injury | 1 | 2020 | 255 | 0.580 |
Why?
| Fibronectins | 3 | 2021 | 108 | 0.570 |
Why?
| Aspirin | 1 | 2020 | 324 | 0.560 |
Why?
| Protein Processing, Post-Translational | 3 | 2016 | 399 | 0.560 |
Why?
| Cell Line | 7 | 2020 | 2637 | 0.560 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 299 | 0.560 |
Why?
| Lipid Bilayers | 2 | 2010 | 99 | 0.560 |
Why?
| MAP Kinase Signaling System | 2 | 2018 | 276 | 0.550 |
Why?
| Immunohistochemistry | 6 | 2019 | 1629 | 0.540 |
Why?
| Aged | 23 | 2023 | 19074 | 0.540 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 249 | 0.530 |
Why?
| Mice, Inbred C57BL | 7 | 2023 | 4694 | 0.520 |
Why?
| Cells, Cultured | 11 | 2018 | 3886 | 0.500 |
Why?
| Protein Aggregation, Pathological | 1 | 2015 | 14 | 0.490 |
Why?
| HSP20 Heat-Shock Proteins | 1 | 2015 | 1 | 0.490 |
Why?
| Histones | 1 | 2020 | 535 | 0.480 |
Why?
| Pericytes | 2 | 2005 | 24 | 0.470 |
Why?
| Endothelial Cells | 3 | 2018 | 687 | 0.470 |
Why?
| Imidazoles | 4 | 2010 | 208 | 0.460 |
Why?
| Eye Diseases | 1 | 2015 | 76 | 0.460 |
Why?
| Lactoylglutathione Lyase | 3 | 2009 | 6 | 0.460 |
Why?
| Tryptophan | 6 | 2013 | 136 | 0.450 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2018 | 797 | 0.450 |
Why?
| Brain Diseases | 1 | 2015 | 125 | 0.450 |
Why?
| Fibrosis | 1 | 2016 | 453 | 0.440 |
Why?
| Mice, Knockout | 5 | 2020 | 2570 | 0.430 |
Why?
| Retinal Vessels | 3 | 2018 | 50 | 0.430 |
Why?
| Pyrimidines | 5 | 2008 | 376 | 0.430 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2013 | 42 | 0.420 |
Why?
| Spectrometry, Fluorescence | 6 | 2011 | 157 | 0.420 |
Why?
| Hydrophobic and Hydrophilic Interactions | 5 | 2013 | 176 | 0.410 |
Why?
| Glyoxal | 2 | 2004 | 11 | 0.410 |
Why?
| Disulfides | 2 | 2023 | 90 | 0.410 |
Why?
| Proteins | 4 | 2000 | 908 | 0.410 |
Why?
| Solubility | 2 | 2023 | 223 | 0.400 |
Why?
| Protein Structure, Tertiary | 6 | 2013 | 796 | 0.400 |
Why?
| Mass Spectrometry | 5 | 2019 | 633 | 0.390 |
Why?
| Interferon-gamma | 3 | 2018 | 719 | 0.390 |
Why?
| Water | 3 | 2023 | 396 | 0.390 |
Why?
| Circular Dichroism | 4 | 2019 | 135 | 0.380 |
Why?
| Organ Culture Techniques | 5 | 2019 | 140 | 0.380 |
Why?
| HeLa Cells | 4 | 2016 | 562 | 0.380 |
Why?
| Caspase 3 | 5 | 2013 | 235 | 0.370 |
Why?
| Citrate (si)-Synthase | 4 | 2020 | 46 | 0.370 |
Why?
| Protein Structure, Secondary | 5 | 2013 | 325 | 0.370 |
Why?
| Middle Aged | 17 | 2021 | 26737 | 0.370 |
Why?
| Intraocular Pressure | 2 | 2022 | 276 | 0.360 |
Why?
| Proto-Oncogene Proteins c-fyn | 1 | 2010 | 12 | 0.350 |
Why?
| Aquaporins | 1 | 2010 | 8 | 0.350 |
Why?
| Caspase 9 | 4 | 2013 | 48 | 0.350 |
Why?
| Cellular Senescence | 2 | 2009 | 152 | 0.340 |
Why?
| Myristic Acid | 2 | 2010 | 10 | 0.340 |
Why?
| Gene Expression Regulation | 1 | 2019 | 2320 | 0.340 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2010 | 83 | 0.340 |
Why?
| Apoptosis Regulatory Proteins | 2 | 2010 | 171 | 0.330 |
Why?
| Membrane Lipids | 1 | 2010 | 87 | 0.330 |
Why?
| Rats | 7 | 2022 | 4958 | 0.330 |
Why?
| Protein Denaturation | 3 | 2020 | 68 | 0.330 |
Why?
| Amino Acid Sequence | 6 | 2015 | 1982 | 0.330 |
Why?
| Protein Conformation | 5 | 2019 | 805 | 0.320 |
Why?
| Actins | 3 | 2020 | 381 | 0.320 |
Why?
| Cross-Linking Reagents | 5 | 2020 | 181 | 0.320 |
Why?
| Protein Folding | 1 | 2010 | 239 | 0.310 |
Why?
| Structure-Activity Relationship | 4 | 2015 | 502 | 0.300 |
Why?
| Capillaries | 2 | 2005 | 91 | 0.300 |
Why?
| Electrophoresis, Polyacrylamide Gel | 5 | 2018 | 318 | 0.300 |
Why?
| gamma-Crystallins | 2 | 2020 | 2 | 0.300 |
Why?
| Glucose | 4 | 2013 | 897 | 0.290 |
Why?
| Protein Binding | 4 | 2020 | 1890 | 0.290 |
Why?
| Cloning, Molecular | 4 | 2010 | 522 | 0.280 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 270 | 0.280 |
Why?
| Cricetulus | 3 | 2013 | 97 | 0.280 |
Why?
| CHO Cells | 3 | 2013 | 138 | 0.280 |
Why?
| Lens Diseases | 1 | 2006 | 1 | 0.270 |
Why?
| Pyridoxamine | 1 | 2006 | 1 | 0.270 |
Why?
| Pyrroles | 4 | 1996 | 181 | 0.270 |
Why?
| Cricetinae | 3 | 2013 | 253 | 0.270 |
Why?
| Diabetes Mellitus | 6 | 2021 | 900 | 0.270 |
Why?
| Adult | 16 | 2020 | 30550 | 0.270 |
Why?
| Cytokines | 1 | 2013 | 1841 | 0.260 |
Why?
| Dose-Response Relationship, Drug | 5 | 2013 | 1842 | 0.260 |
Why?
| Cell Cycle | 1 | 2008 | 542 | 0.250 |
Why?
| Reactive Oxygen Species | 5 | 2018 | 531 | 0.250 |
Why?
| Histidine | 1 | 2005 | 57 | 0.240 |
Why?
| Serum Albumin | 2 | 2008 | 137 | 0.240 |
Why?
| Protein Transport | 3 | 2015 | 395 | 0.240 |
Why?
| Diabetes Complications | 1 | 2006 | 211 | 0.240 |
Why?
| Down-Regulation | 3 | 2013 | 594 | 0.240 |
Why?
| Rats, Sprague-Dawley | 4 | 2015 | 2218 | 0.230 |
Why?
| Protein Aggregates | 2 | 2015 | 65 | 0.230 |
Why?
| Molecular Sequence Data | 4 | 2015 | 2785 | 0.230 |
Why?
| Enzyme Activation | 3 | 2010 | 785 | 0.230 |
Why?
| Protein Kinase C | 1 | 2005 | 273 | 0.220 |
Why?
| Temperature | 2 | 2020 | 565 | 0.210 |
Why?
| Axonal Transport | 1 | 2022 | 21 | 0.210 |
Why?
| Neuroprotection | 1 | 2022 | 30 | 0.200 |
Why?
| Oxidation-Reduction | 2 | 2017 | 923 | 0.200 |
Why?
| Signal Transduction | 4 | 2021 | 4513 | 0.200 |
Why?
| Mutation | 2 | 2015 | 3346 | 0.190 |
Why?
| Lipids | 1 | 2005 | 580 | 0.190 |
Why?
| Capsulorhexis | 1 | 2021 | 8 | 0.190 |
Why?
| Age Factors | 3 | 2019 | 2894 | 0.190 |
Why?
| Mice, Inbred BALB C | 2 | 2019 | 1144 | 0.190 |
Why?
| Cytochromes c | 2 | 2013 | 63 | 0.190 |
Why?
| Malate Dehydrogenase | 1 | 2020 | 1 | 0.180 |
Why?
| Norleucine | 3 | 1996 | 3 | 0.170 |
Why?
| Mutagenesis, Site-Directed | 3 | 2015 | 345 | 0.170 |
Why?
| Young Adult | 4 | 2020 | 10470 | 0.170 |
Why?
| Mice, Transgenic | 3 | 2010 | 1949 | 0.170 |
Why?
| Blood Glucose | 2 | 2021 | 1828 | 0.170 |
Why?
| Phosphorylation | 4 | 2010 | 1569 | 0.170 |
Why?
| Paraffin Embedding | 1 | 2019 | 21 | 0.170 |
Why?
| Mice, 129 Strain | 1 | 2020 | 75 | 0.170 |
Why?
| Excitatory Amino Acid Antagonists | 1 | 2020 | 87 | 0.170 |
Why?
| Membrane Proteins | 2 | 2019 | 1019 | 0.170 |
Why?
| Oxalates | 1 | 1999 | 10 | 0.170 |
Why?
| Multiprotein Complexes | 1 | 2020 | 140 | 0.160 |
Why?
| Antibody Specificity | 3 | 2009 | 176 | 0.160 |
Why?
| Models, Molecular | 3 | 2014 | 1369 | 0.160 |
Why?
| Succinates | 1 | 2019 | 18 | 0.160 |
Why?
| Oxidative Stress | 1 | 2005 | 1076 | 0.160 |
Why?
| Cytosol | 1 | 2019 | 208 | 0.160 |
Why?
| Adolescent | 7 | 2020 | 17848 | 0.160 |
Why?
| Aged, 80 and over | 8 | 2015 | 6347 | 0.160 |
Why?
| Gain of Function Mutation | 1 | 2019 | 30 | 0.160 |
Why?
| Tumor Cells, Cultured | 1 | 2020 | 849 | 0.160 |
Why?
| Cytoskeletal Proteins | 1 | 2019 | 145 | 0.160 |
Why?
| Amino Acids | 2 | 2015 | 448 | 0.150 |
Why?
| Endothelium, Vascular | 1 | 2004 | 847 | 0.150 |
Why?
| Retinal Degeneration | 1 | 2018 | 30 | 0.150 |
Why?
| Magnetic Resonance Spectroscopy | 4 | 2007 | 473 | 0.150 |
Why?
| Mitochondrial Proteins | 1 | 2019 | 219 | 0.150 |
Why?
| Antioxidants | 2 | 2015 | 530 | 0.140 |
Why?
| Collagen | 2 | 1996 | 415 | 0.140 |
Why?
| Deoxyglucose | 2 | 1996 | 43 | 0.140 |
Why?
| Snail Family Transcription Factors | 1 | 2016 | 19 | 0.130 |
Why?
| Male | 7 | 2021 | 55599 | 0.130 |
Why?
| Dura Mater | 1 | 1996 | 27 | 0.130 |
Why?
| Basement Membrane | 1 | 2016 | 30 | 0.130 |
Why?
| Smad3 Protein | 1 | 2016 | 41 | 0.130 |
Why?
| Smad2 Protein | 1 | 2016 | 33 | 0.130 |
Why?
| Monosaccharides | 3 | 2003 | 11 | 0.130 |
Why?
| Smad4 Protein | 1 | 2016 | 34 | 0.130 |
Why?
| Caproates | 1 | 1995 | 4 | 0.130 |
Why?
| Spectrophotometry | 3 | 2005 | 48 | 0.130 |
Why?
| Microscopy, Fluorescence | 2 | 2008 | 396 | 0.120 |
Why?
| Selenious Acid | 1 | 2015 | 2 | 0.120 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 398 | 0.120 |
Why?
| Photobleaching | 1 | 2015 | 20 | 0.120 |
Why?
| Binding, Competitive | 3 | 2008 | 193 | 0.120 |
Why?
| Injections, Intraperitoneal | 1 | 2015 | 99 | 0.120 |
Why?
| Models, Biological | 3 | 2010 | 1621 | 0.120 |
Why?
| Blood Proteins | 4 | 1999 | 231 | 0.120 |
Why?
| Heat-Shock Response | 1 | 2015 | 46 | 0.120 |
Why?
| Glycoproteins | 1 | 1996 | 304 | 0.120 |
Why?
| Caspases | 2 | 2006 | 245 | 0.110 |
Why?
| Peroxynitrous Acid | 1 | 2013 | 11 | 0.110 |
Why?
| Glycine | 1 | 2014 | 152 | 0.110 |
Why?
| Cell Movement | 1 | 2018 | 869 | 0.110 |
Why?
| NG-Nitroarginine Methyl Ester | 1 | 2013 | 38 | 0.110 |
Why?
| Proto-Oncogene Proteins | 2 | 2010 | 608 | 0.110 |
Why?
| Recombinant Proteins | 2 | 2008 | 1230 | 0.110 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2013 | 157 | 0.110 |
Why?
| RNA | 1 | 2019 | 809 | 0.110 |
Why?
| Flow Cytometry | 2 | 2008 | 1083 | 0.100 |
Why?
| Extracellular Matrix | 1 | 2016 | 436 | 0.100 |
Why?
| Insulin | 3 | 2008 | 2080 | 0.100 |
Why?
| Enzyme Inhibitors | 2 | 2010 | 750 | 0.100 |
Why?
| Ribose | 1 | 1992 | 18 | 0.100 |
Why?
| Transfection | 2 | 2004 | 866 | 0.100 |
Why?
| Amino Acid Motifs | 1 | 2012 | 197 | 0.100 |
Why?
| Acetic Anhydrides | 1 | 2011 | 1 | 0.100 |
Why?
| Cell Nucleus | 1 | 2015 | 554 | 0.100 |
Why?
| RNA Interference | 1 | 2013 | 433 | 0.100 |
Why?
| Stress, Physiological | 1 | 2015 | 378 | 0.100 |
Why?
| Dogs | 3 | 2005 | 334 | 0.100 |
Why?
| Cell Membrane | 2 | 2005 | 680 | 0.100 |
Why?
| Mutant Proteins | 1 | 2011 | 95 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 923 | 0.090 |
Why?
| Retina | 1 | 2013 | 263 | 0.090 |
Why?
| Interleukin-1beta | 1 | 2013 | 370 | 0.090 |
Why?
| Glutamine | 1 | 2011 | 91 | 0.090 |
Why?
| Base Sequence | 2 | 2015 | 2114 | 0.090 |
Why?
| Inflammation Mediators | 1 | 2013 | 477 | 0.090 |
Why?
| Drug Antagonism | 1 | 2010 | 8 | 0.090 |
Why?
| Oncogene Protein v-akt | 1 | 2010 | 26 | 0.090 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2010 | 73 | 0.090 |
Why?
| Bcl-2-Like Protein 11 | 1 | 2010 | 37 | 0.090 |
Why?
| Resins, Synthetic | 1 | 2009 | 13 | 0.090 |
Why?
| Buffers | 1 | 2009 | 53 | 0.090 |
Why?
| Edetic Acid | 1 | 2009 | 47 | 0.090 |
Why?
| Phosphatidylinositol 3-Kinase | 1 | 2010 | 26 | 0.080 |
Why?
| bcl-2-Associated X Protein | 1 | 2010 | 45 | 0.080 |
Why?
| Fluorescence | 3 | 2015 | 148 | 0.080 |
Why?
| Caspase Inhibitors | 1 | 2010 | 78 | 0.080 |
Why?
| Models, Chemical | 2 | 2005 | 248 | 0.080 |
Why?
| Thermodynamics | 1 | 2011 | 382 | 0.080 |
Why?
| DNA Primers | 1 | 2010 | 510 | 0.080 |
Why?
| Surface Properties | 1 | 2010 | 387 | 0.080 |
Why?
| PTEN Phosphohydrolase | 1 | 2010 | 140 | 0.080 |
Why?
| Umbilical Veins | 2 | 2008 | 58 | 0.080 |
Why?
| RNA, Messenger | 1 | 2016 | 2553 | 0.080 |
Why?
| Myosin Type II | 1 | 2008 | 10 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1140 | 0.080 |
Why?
| Nitric Oxide | 1 | 2013 | 823 | 0.080 |
Why?
| Doxorubicin | 1 | 2010 | 285 | 0.080 |
Why?
| Homoarginine | 1 | 2008 | 2 | 0.080 |
Why?
| Methylurea Compounds | 1 | 2008 | 7 | 0.080 |
Why?
| Sulfhydryl Compounds | 1 | 2010 | 177 | 0.080 |
Why?
| Hydrogen Peroxide | 1 | 2009 | 288 | 0.080 |
Why?
| Antibodies | 2 | 2000 | 371 | 0.070 |
Why?
| In Vitro Techniques | 1 | 2009 | 1016 | 0.070 |
Why?
| Receptors, Immunologic | 1 | 2008 | 201 | 0.070 |
Why?
| Fatty Acids | 1 | 2010 | 381 | 0.070 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 993 | 0.070 |
Why?
| Frameshift Mutation | 1 | 2007 | 27 | 0.070 |
Why?
| Binding Sites | 1 | 2010 | 1168 | 0.070 |
Why?
| Protein Subunits | 1 | 2008 | 201 | 0.070 |
Why?
| Aldehyde Reductase | 1 | 2006 | 24 | 0.070 |
Why?
| Dimerization | 1 | 2007 | 176 | 0.070 |
Why?
| Female | 5 | 2021 | 59511 | 0.070 |
Why?
| Carbonic Anhydrases | 1 | 2006 | 13 | 0.070 |
Why?
| Amino Acid Substitution | 1 | 2007 | 262 | 0.070 |
Why?
| Biomarkers | 1 | 2016 | 3408 | 0.060 |
Why?
| Iodides | 1 | 2005 | 6 | 0.060 |
Why?
| Myristic Acids | 1 | 2005 | 8 | 0.060 |
Why?
| Ninhydrin | 1 | 2005 | 1 | 0.060 |
Why?
| Chromatography, Gel | 1 | 2005 | 122 | 0.060 |
Why?
| Diffusion | 1 | 2005 | 119 | 0.060 |
Why?
| Time Factors | 2 | 2005 | 6116 | 0.060 |
Why?
| Alzheimer Disease | 1 | 2010 | 442 | 0.060 |
Why?
| Cytoplasm | 1 | 2005 | 255 | 0.060 |
Why?
| Mitochondria | 1 | 2010 | 747 | 0.060 |
Why?
| Acetylcysteine | 1 | 2005 | 141 | 0.060 |
Why?
| Reproducibility of Results | 1 | 2011 | 2765 | 0.060 |
Why?
| Fluorescence Resonance Energy Transfer | 1 | 2005 | 170 | 0.060 |
Why?
| Anilino Naphthalenesulfonates | 1 | 2003 | 10 | 0.060 |
Why?
| Alcohol Dehydrogenase | 1 | 2003 | 15 | 0.060 |
Why?
| Antigens | 1 | 2005 | 318 | 0.050 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 260 | 0.050 |
Why?
| Microscopy, Confocal | 1 | 2004 | 304 | 0.050 |
Why?
| Cell Differentiation | 1 | 2010 | 1701 | 0.050 |
Why?
| Child | 4 | 2015 | 18415 | 0.050 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 2004 | 278 | 0.050 |
Why?
| Serum Albumin, Bovine | 2 | 2000 | 61 | 0.050 |
Why?
| Oligopeptides | 1 | 2004 | 236 | 0.050 |
Why?
| Reference Values | 2 | 1996 | 743 | 0.050 |
Why?
| Cell Proliferation | 1 | 2008 | 2187 | 0.050 |
Why?
| Carbohydrate Metabolism | 1 | 2001 | 48 | 0.050 |
Why?
| Hyperglycemia | 1 | 2004 | 292 | 0.050 |
Why?
| Serum Albumin, Human | 1 | 2000 | 3 | 0.050 |
Why?
| Oxygen | 1 | 2005 | 854 | 0.040 |
Why?
| Alkanes | 1 | 1999 | 14 | 0.040 |
Why?
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1999 | 134 | 0.040 |
Why?
| Molecular Structure | 2 | 1997 | 434 | 0.040 |
Why?
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 49 | 0.040 |
Why?
| Amides | 1 | 1999 | 86 | 0.040 |
Why?
| Glyceraldehyde | 1 | 1997 | 2 | 0.040 |
Why?
| Guanidines | 1 | 1997 | 33 | 0.040 |
Why?
| Rabbits | 1 | 1998 | 733 | 0.040 |
Why?
| Glycosuria | 1 | 1996 | 8 | 0.030 |
Why?
| Aminocaproates | 1 | 1995 | 2 | 0.030 |
Why?
| Ribonuclease, Pancreatic | 1 | 1995 | 11 | 0.030 |
Why?
| Scattering, Radiation | 1 | 2015 | 92 | 0.030 |
Why?
| Protein Unfolding | 1 | 2014 | 31 | 0.030 |
Why?
| Kinetics | 1 | 1997 | 1551 | 0.030 |
Why?
| Child, Preschool | 1 | 2007 | 9116 | 0.030 |
Why?
| Pronase | 1 | 1992 | 5 | 0.030 |
Why?
| Hydrolysis | 1 | 1991 | 173 | 0.020 |
Why?
| Molecular Weight | 1 | 1991 | 331 | 0.020 |
Why?
| Pigmentation | 1 | 1991 | 55 | 0.020 |
Why?
| NADPH Oxidase 4 | 1 | 2008 | 8 | 0.020 |
Why?
| Vascular Cell Adhesion Molecule-1 | 1 | 2008 | 35 | 0.020 |
Why?
| Uremia | 1 | 2008 | 14 | 0.020 |
Why?
| NADPH Oxidase 2 | 1 | 2008 | 42 | 0.020 |
Why?
| NADPH Oxidases | 1 | 2008 | 120 | 0.020 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2008 | 154 | 0.020 |
Why?
| Membrane Glycoproteins | 1 | 2008 | 430 | 0.020 |
Why?
| Hippocampus | 1 | 2010 | 693 | 0.020 |
Why?
| NF-kappa B | 1 | 2008 | 641 | 0.010 |
Why?
| Immunoglobulin G | 1 | 2008 | 770 | 0.010 |
Why?
| Case-Control Studies | 1 | 2010 | 3003 | 0.010 |
Why?
| Neurons | 1 | 2010 | 1280 | 0.010 |
Why?
| Peritoneal Dialysis | 1 | 1996 | 84 | 0.010 |
Why?
| Renal Dialysis | 1 | 1996 | 374 | 0.010 |
Why?
| Kidney Failure, Chronic | 1 | 1996 | 489 | 0.010 |
Why?
|
|
Nagaraj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|